Gene · 2331
Papers3,504
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,504
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican. | Cancers (Basel) | 2023 | 37509212 | PubTator, text mining | PubMed |
| Small Leucine-Rich Proteoglycan PODNL1 Identified as a Potential Tumor Matrix-Mediated Biomarker for Prognosis and Immunotherapy in a Pan-Cancer Setting. | Curr Issues Mol Biol | 2023 | 37504302 | PubTator, text mining | PubMed |
| Alpha-Lipoic Acid, Auraptene, and Particularly Their Combination Prevent the Metastasis of U87 Human Glioblastoma Cells. | Evid Based Complement Alternat Med | 2023 | 37496822 | PubTator, text mining | PubMed |
| Voice pitch is negatively associated with sociosexual behavior in males but not in females. | Front Psychol | 2023 | 37496795 | PubTator, text mining | PubMed |
| The role of fibromodulin in inflammatory responses and diseases associated with inflammation. | Front Immunol | 2023 | 37483637 | PubTator, text mining | PubMed |
| Fat-free mass and resting metabolic rate are determinants of energy intake: implications for a theory of appetite control. | Philos Trans R Soc Lond B Biol Sci | 2023 | 37482777 | PubTator, text mining | PubMed |
| PCDH7 as the key gene related to the co-occurrence of sarcopenia and osteoporosis. | Front Genet | 2023 | 37476411 | PubTator, text mining | PubMed |
| Innovative molecular subtypes of multiple signaling pathways in colon cancer and validation of FMOD as a prognostic-related marker. | J Cancer Res Clin Oncol | 2023 | 37474678 | PubTator, text mining | PubMed |
| Combining biomechanical stimulation and chronobiology: a novel approach for augmented chondrogenesis? | Front Bioeng Biotechnol | 2023 | 37456723 | PubTator, text mining | PubMed |
| Vessels that encapsulate tumour clusters vascular pattern in hepatocellular carcinoma. | JHEP Rep | 2023 | 37456680 | PubTator, text mining | PubMed |
| Acoustic analysis in stuttering: a machine-learning study. | Front Neurol | 2023 | 37456655 | PubTator, text mining | PubMed |
| Risk factors associated with cesarean section and adverse fetal outcomes in intrahepatic cholestasis of pregnancy. | Front Pediatr | 2023 | 37456565 | PubTator, text mining | PubMed |
| Exploring the Interplay between Polyphenols and Lysyl Oxidase Enzymes for Maintaining Extracellular Matrix Homeostasis. | Int J Mol Sci | 2023 | 37446164 | PubTator, text mining | PubMed |
| Nanopeptide C-I20 as a novel feed additive effectively alleviates detrimental impacts of soybean meal on mandarin fish by improving the intestinal mucosal barrier. | Front Immunol | 2023 | 37435065 | PubTator, text mining | PubMed |
| In vitro strategies for mimicking dynamic cell-ECM reciprocity in 3D culture models. | Front Bioeng Biotechnol | 2023 | 37434756 | PubTator, text mining | PubMed |
Protocol for the mixed methods, Managing young people (aged 16-25) with Attention deficit hyperactivity disorder in Primary care (MAP) study: mapping current practice and co-producing guidance to improve healthcare in an underserved population. | BMJ Open | 2023 | 37429692 | PubTator, text mining | PubMed |
| Impact of dehydration on the physiochemical properties of Nostoc calcicola BOT1 and its untargeted metabolic profiling through UHPLC-HRMS. | Front Plant Sci | 2023 | 37426961 | PubTator, text mining | PubMed |
| Association of amino acids and parameters of bone metabolism with endothelial dysfunction and vasculopathic changes in limited systemic sclerosis. | Front Med (Lausanne) | 2023 | 37425312 | PubTator, text mining | PubMed |
| Identification and quantification of protein nitration sites in human coronary artery smooth muscle cells in the absence and presence of peroxynitrous acid/peroxynitrite. | Redox Biol | 2023 | 37413764 | PubTator, text mining | PubMed |
| A cellular and molecular spatial atlas of dystrophic muscle. | Proc Natl Acad Sci U S A | 2023 | 37410813 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2331/papers?page=17